How much funding has Annoviant, Inc. raised?

Annoviant, Inc. has raised $4.7M in total funding, most recently a Grant round.

Who are Annoviant, Inc.'s investors?

Annoviant, Inc.'s investors include NIH.

When was Annoviant, Inc. founded?

Annoviant, Inc. was founded in 2019.

Where is Annoviant, Inc. headquartered?

Annoviant, Inc. is headquartered in Alpharetta, Georgia, United States.

What industry is Annoviant, Inc. in?

Annoviant, Inc. operates in Healthcare, Medical Devices.

How many employees does Annoviant, Inc. have?

Annoviant, Inc. has 1-10 employees.

Annoviant, Inc.

Innovation that grows with you

Alpharetta, United States · Founded 2019 · $4.7M raised

Healthcare

Medical Devices

Headquarters: Alpharetta, Georgia
Employees: 1–10
Founded: 2019
Business Model: B2B

Website: annoviant.com
Total Funding: $4.7M
Last Round: $2.1M GrantJan 2024
Rounds: 4

About

Annoviant is an Alpharetta, Georgia medical device company developing TxGuard, a patented regenerative tissue technology that grows and heals with patients. The technology addresses calcification, thrombosis, and degeneration in biological prosthetic heart valves, with applications in cardiovascular, urology, gastroenterology, and wound care.

Summary

Annoviant, Inc. is a Healthcare company based in Alpharetta, United States, founded in 2019. It has raised $4.7M in total across 4 rounds, most recently a $2.1M Grant round in Jan 2024. Investors include NIH.